Contact
searchSearch
HMP Global
Login

Advertisement

ADVERTISEMENT

news

Conference Coverage
Dr Chaft Presents Progress for Immune Checkpoint Inhibitors in NSCLC
10/07/2021
Dr Chaft presents progress for immune checkpoint inhibitors in the curative setting of neoadjuvant and adjuvant therapy in resectable NSCLC, and outcomes the role of immunotherapy for patients with early-stage lung cancer.
Dr Chaft presents progress for immune checkpoint inhibitors in the curative setting of neoadjuvant and adjuvant therapy in resectable NSCLC, and outcomes the role of immunotherapy for patients with early-stage lung cancer.
Dr Chaft presents progress for...
10/07/2021
Oncology
Conference Coverage
Dr Lin Shares Systemic Therapies to Overcome Resistance in ALK+ Lung Cancer
10/05/2021
Jessica J. Lin, MD, presents resistance mechanisms inevitable in developing clinical benefits in systemic therapies for patients with advanced ALK+ lung cancer and how to create combination strategies that can overcome disease progression.
Jessica J. Lin, MD, presents resistance mechanisms inevitable in developing clinical benefits in systemic therapies for patients with advanced ALK+ lung cancer and how to create combination strategies that can overcome disease progression.
Jessica J. Lin, MD, presents...
10/05/2021
Oncology
News
Dr Yu Shares Updates of Prevention Efforts in EGFR-Mutant Lung Cancer
10/05/2021
Helena Yu, MD, discusses updates of small cell histologic transformation in EGFR-mutant lung cancers at the virtual 2021 Personalized Therapies in Thoracic Oncology meeting.
Helena Yu, MD, discusses updates of small cell histologic transformation in EGFR-mutant lung cancers at the virtual 2021 Personalized Therapies in Thoracic Oncology meeting.
Helena Yu, MD, discusses updates...
10/05/2021
Oncology
News
Angioinhibition in the Management of NSCLC
12/11/2020
Edward B. Garon MD, MS, engaged in a stimulating debate regarding the relevancy of angioinhibition in the management of NSCLC, particularly for EGFR-positive patients, at the virtual 2020 Personalized Therapies in Thoracic Oncology meeting.
Edward B. Garon MD, MS, engaged in a stimulating debate regarding the relevancy of angioinhibition in the management of NSCLC, particularly for EGFR-positive patients, at the virtual 2020 Personalized Therapies in Thoracic Oncology meeting.
Edward B. Garon MD, MS, engaged...
12/11/2020
Oncology
News
Targeted Therapy Options for MET-Dependent Lung Cancer
11/20/2020
In a session presented at the 2020 Personalized Therapies in Thoracic Oncology virtual meeting, Alexander Drilon PhD, Memorial Sloan Kettering Cancer Center, New York, shared insight on MET-dependent lung cancer.
In a session presented at the 2020 Personalized Therapies in Thoracic Oncology virtual meeting, Alexander Drilon PhD, Memorial Sloan Kettering Cancer Center, New York, shared insight on MET-dependent lung cancer.
In a session presented at the...
11/20/2020
Oncology
News
Basics of Immunotherapy in SCLC
10/03/2020
In a session presented at the 2020 Personalized Therapies in Thoracic Oncology virtual meeting, Stephen V. Liu, MD, Georgetown Lombardi Comprehensive Cancer Center, Washington, D.C, shared insight on immunotherapy treatment for SCLC. 
In a session presented at the 2020 Personalized Therapies in Thoracic Oncology virtual meeting, Stephen V. Liu, MD, Georgetown Lombardi Comprehensive Cancer Center, Washington, D.C, shared insight on immunotherapy treatment for SCLC. 
In a session presented at the...
10/03/2020
Oncology
News
Basics of Immunotherapy in SCLC
10/03/2020
In a session presented at the 2020 Personalized Therapies in Thoracic Oncology virtual meeting, Stephen V. Liu, MD, Georgetown Lombardi Comprehensive Cancer Center, Washington, D.C, shared insight on immunotherapy treatment for SCLC. 
In a session presented at the 2020 Personalized Therapies in Thoracic Oncology virtual meeting, Stephen V. Liu, MD, Georgetown Lombardi Comprehensive Cancer Center, Washington, D.C, shared insight on immunotherapy treatment for SCLC. 
In a session presented at the...
10/03/2020
Oncology

Advertisement

About

Formerly known as Perspectives in Thoracic Oncology, the lung cancer meeting you know and love is getting a makeover. With an updated name to reflect a more pronounced focus on targeted therapies, biomarker testing and precision medicine, year 25 of this educational gathering is getting practical. Personalized Therapies in Thoracic Oncology will go beyond chemotherapy and focus on the best way to treat your patients when traditional methods aren't cutting it. 

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use